Expiration date: November 2006
Estimated time to complete activity: 1.75 hours
Hardware and software requirements:
Windows machine:
450 MHz Intel Pentium II processor (or equivalent) and later, with 128 MB RAM, Internet connection, Internet browser, Macromedia Flash 7.0 or higher
Macintosh machine:
500 MHz PowerPC G3 and later, with 128 MB RAM, Internet connection, Internet browser, Macromedia Flash 7.0 or higher Additional configurations may also work. Check this site for Flash compatibility of your system: http://www.macromedia.com/software/flashplayer/productinfo/systemreqs/flashplayer7/
Jointly sponsored by Postgraduate Institute for Medicine and Advanced Concepts Institute, University of the Sciences in Philadelphia.
 367 Inverness Parkway Englewood, CO 80112 (303) 799-1930 phone (303) 858-8842 fax http://www.pimed.com/ |
 600 S. 43rd Street Philadelphia, PA 19104 (215) 596-8800 (215) 596-8598 http://www.usip.edu/ |
This activity is supported by an educational grant from Eli Lilly and Company
This activity has been designed to meet the educational needs of internal medicine and primary care physicians involved in the care of patients with depression.
Statement of Need/Program Overview
Depression, a serious chronic psychiatric disorder, is ranked as the world's fourth most common health problem.[1] The costs for a depressed patient can be calculated anywhere from 50% to 100% higher than those of an nondepressed patient,[2] accounting for almost $50 billion in indirect and direct medical costs each year. Primary care physicians are on the forefront of diagnosing and treating these patients. Recent estimates propose that symptoms consistent with depression are present in nearly 70% of patients who visit primary care physicians. Approximately 35% of patients who are seen in the primary care setting meet the criteria for being diagnosed with some form of depression, with 10% of patients suffering from major depression.[3] For this reason, primary care physicians play a critical role in efficiently diagnosing and treating depression. This case-based activity will help provide primary care with additional knowledge in treatment and monitoring plans, increasing patient adherence, and pharmacologic agents available for the treatment of depression.
- Schulberg HC, Katon WJ, Simon GE, Rush AJ. Best clinical practice: guidelines for managing major depression in primary medical care. J Clin Psychiatry 1999;60(suppl 7):19-26.
- Rice DP, Miller LS. Health, economics, and cost implications of anxiety and other mental disorders in the United States. Br J Psychiatry 1998;34(suppl):4-9.
- Montano CB, Montano MB. A new paradigm for treating depression in the primary care setting [monograph on the Internet]. Medscape Medical News; 2002 [cited 2004 Oct 10]. Available from: www.medscape.com/viewprogram/2022_pnt.
After completing this activity, the participant should be better able to:
Faculty
Charles DeBattista, D.M.H.,MD
Depression Research Clinic
Department of Psychiatry
Stanford University School of Medicine
Gerry Maguire, MD
Assistant Clinical Professor
Acting Assistant Dean for CME
Director of Residency Training
Department of Psychiatry
University of California, Irvine College of Medicine
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Postgraduate Institute for Medicine (PIM) and Advanced Concepts Institute (ACI). The PIM is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The PIM designates this educational activity for a maximum of 2 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.
Disclosure of Conflicts of Interest
PIM assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The following faculty reported a real or apparent conflict of interest:
| Name of Faculty | Reported Areas of Conflict | |
| Charles DeBattista, D.M.H.,MD | Grant/Research Support: Cephalon, Cyberonics, Neuronetics, NIMH, Pritzker Foundation, Sommerset, Wyeth | |
| Consultant : Bristol-Myers Squibb, Corcept Therapeutics, Lilly, WyethStockholder : Corcept Therapeutics Speakers' Bureau : Abbott Laboratories, Bristol-Myers Squibb, Cephalon, GlaxoSmithKline, Lilly, Pfizer, Wyeth | ||
| Gerry Maguire, MD | Grant/Research Support: Eli Lilly, Forest Pharmaceuticals, Novartis, PfizerConsultant: Eli LillySpeakers' Bureau: Eli Lilly, Pfizer |
The following planners and managers reported a real or apparent conflict of interest:
| Name of Planner or Manager | Reported Areas of Conflict | |
| Susan Connelly, PharmD | None | |
| Linda Graham, RN | None | |
| Jan Hixon, RN | None | |
| Trace Hutchison, PharmD | None |
Method of Participation
Continuing education credit will be awarded at no cost to participants who successfully complete the activity, receive a score of 70% or better on the assessment and electronically submit a program evaluation. A statement of credit indicating the number of hours it took the participant to complete the activity and how many CEUs they will receive based on this information can be printed immediately from the website upon completion of the activity.
Media
Internet
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. PIM, ACI and Eli Lilly and Company (Lilly) do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, ACI, and Lilly. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
